Coppey L J, Gellett J S, Davidson E P, Dunlap J A, Lund D D, Yorek M A
Diabetes Endocrinology Research Center, Veterans Affairs Medical Center, University of Iowa, Iowa City, Iowa 52246, USA.
Diabetes. 2001 Aug;50(8):1927-37. doi: 10.2337/diabetes.50.8.1927.
We have shown that diabetes-induced reduction in endoneurial blood flow (EBF) and impaired endothelium-dependent vascular relaxation precede slowing of motor nerve conduction velocity (MNCV) and decreased sciatic nerve Na(+)/K(+) ATPase activity. Furthermore, vascular dysfunction was accompanied by an accumulation of superoxide in arterioles that provide circulation to the sciatic nerve. In the present study, we examined the effect that treatment of streptozotocin-induced diabetic rats with antioxidants has on vascular and neural function. Diabetic rats were treated with 0.5% alpha-lipoic acid as a diet supplement or with hydroxyethyl starch deferoxamine (HES-DFO) by weekly intravenous injections at a dose of 75 mg/kg. The treatments significantly improved diabetes-induced decrease in EBF, acetylcholine-mediated vascular relaxation in arterioles that provide circulation to the region of the sciatic nerve, and MNCV. The treatments also reduced the production of superoxide by the aorta and superoxide and peroxynitrite by arterioles that provide circulation to the region of the sciatic nerve. Treating diabetic rats with alpha-lipoic acid prevented the diabetes-induced increase in thiobarbituric acid-reactive substances in serum and significantly improved lens glutathione levels. In contrast, treating diabetic rats with HES-DFO did not prevent diabetes-induced changes of either of these markers of oxidative stress. Diabetes-induced increase in sciatic nerve conjugated diene levels was not improved by treatment with either alpha-lipoic acid or HES-DFO. Treating diabetic rats with alpha-lipoic acid but not HES-DFO partially improved sciatic nerve Na(+)/K(+) ATPase activity and myo-inositol content. The increase in sciatic nerve sorbitol levels in diabetic rats was unchanged by either treatment. These studies suggest that diabetes-induced oxidative stress and the generation of superoxide may be partially responsible for the development of diabetic vascular and neural complications.
我们已经表明,糖尿病引起的神经内膜血流量(EBF)减少和内皮依赖性血管舒张功能受损先于运动神经传导速度(MNCV)减慢和坐骨神经钠/钾ATP酶活性降低。此外,血管功能障碍伴随着为坐骨神经提供循环的小动脉中超氧化物的积累。在本研究中,我们研究了用抗氧化剂治疗链脲佐菌素诱导的糖尿病大鼠对血管和神经功能的影响。糖尿病大鼠通过每周静脉注射75mg/kg的剂量,用0.5%的α-硫辛酸作为饮食补充剂或用羟乙基淀粉去铁胺(HES-DFO)进行治疗。这些治疗显著改善了糖尿病引起的EBF降低、乙酰胆碱介导的为坐骨神经区域提供循环的小动脉中的血管舒张以及MNCV。这些治疗还减少了主动脉中超氧化物的产生以及为坐骨神经区域提供循环的小动脉中超氧化物和过氧亚硝酸盐的产生。用α-硫辛酸治疗糖尿病大鼠可防止糖尿病引起的血清中硫代巴比妥酸反应性物质增加,并显著提高晶状体谷胱甘肽水平。相比之下,用HES-DFO治疗糖尿病大鼠并不能预防糖尿病引起的这些氧化应激标志物中的任何一种变化。用α-硫辛酸或HES-DFO治疗均未改善糖尿病引起的坐骨神经共轭二烯水平升高。用α-硫辛酸而不是HES-DFO治疗糖尿病大鼠可部分改善坐骨神经钠/钾ATP酶活性和肌醇含量。两种治疗均未改变糖尿病大鼠坐骨神经山梨醇水平的升高。这些研究表明,糖尿病引起的氧化应激和超氧化物的产生可能部分导致糖尿病血管和神经并发症的发生。